# Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality

> **NCT00144638** · — · COMPLETED · sponsor: **Danish Procalcitonin Study Group** · enrollment: 450 (—)

## Conditions studied

- Sepsis - to Reduce Mortality in the Intensive Care Unit

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00144638
- **Lead sponsor:** Danish Procalcitonin Study Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2003-01
- **Target enrollment:** 450 (—)
- **Last updated:** 2005-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144638, "Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00144638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*